Advertisement

Topics

US hedge funds reduce Teva exposure

13:29 EST 15 Nov 2017 | Globes

Some financial institutions see an opportunity in Teva's low share price and have increased their holdings in the company

Original Article: US hedge funds reduce Teva exposure

NEXT ARTICLE

More From BioPortfolio on "US hedge funds reduce Teva exposure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...